2 unchanged sentences
Incorporated by Reference
−Removed: Purchase and Sale Agreement, by and between HCW Biologics Inc.
−Removed: and Wai 3300Corporate Way, LLC, dated May 27, 2022.
+Added: Loan Agreement by and between HCW Biologics Inc.
+Added: and Cogent Bank, dated August 15, 2022.
+Added: Mortgage and Security Agreement by and between HCW Biologics Inc.
+Added: and Cogent Bank, dated August 15, 2022.
+Added: Capital on Demand TM Sales Agreement, dated August 19, 2022, by and between HCW Biologics Inc.
+Added: and Jones Trading Institutional Services LLC
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
4 unchanged sentences
Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, formatted in Inline XBRL (eXtensible Business Reporting Language):
−Removed: (i) the Condensed Balance Sheets as of December 31, 2021 and June 30, 2022 (unaudited);
−Removed: (ii) the Condensed Statements of Operations for the three months and six months ended June 30, 2021 (unaudited) and June 30, 2022 (unaudited);
+Added: The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, formatted in Inline XBRL (eXtensible Business Reporting Language):
+Added: (i) the Condensed Balance Sheets as of December 31, 2021 and September 30, 2022 (unaudited);
+Added: (ii) the Condensed Statements of Operations for the three months and nine months ended September 30, 2021 (unaudited) and September 30, 2022 (unaudited);
(iv) the Condensed Statements of Stockholders’
−Removed: Equity for the three and six months ended June 30, 2021 (unaudited) and June 30, 2022 (unaudited);
−Removed: (v) the Condensed Statements of Cash Flows for the six months ended June 30, 2021 (unaudited) and June 30, 2022 (unaudited);
+Added: Equity for the three and nine months ended September 30, 2021 (unaudited) and September 30, 2022 (unaudited);
+Added: (v) the Condensed Statements of Cash Flows for the nine months ended September 30, 2021 (unaudited) and September 30, 2022 (unaudited);
and (vi) the notes to the Condensed Financial Statements (unaudited).
1 unchanged sentence
This certification is deemed not filed for purpose of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
−Removed: The exhibits and schedules to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K.
−Removed: The Registrant agrees to furnish supplementally copies of any such exhibits and schedules to the SEC upon request.
−Removed: Certain information in this document has been excluded pursuant to Item 601(b)(10) of Regulation S-K.
−Removed: Such excluded information is not material and would likely cause competitive harm to the Registrant if publicly disclosed.
−Removed: The Registrant agrees to furnish supplementally such information to the SEC upon request.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HCW Biologics Inc.
−Removed: August 12, 2022
+Added: November 7, 2022
Chief Executive Officer
(Principal Executive Officer)
−Removed: August 12, 2022
+Added: November 7, 2022
/s/ Rebecca Byam
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.